- Home
- HLN vs MIST Comparison
HLN vs MIST Comparison
Compare HLN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- MIST
- Stock Information
- Founded
- HLN 2022
- MIST 2003
- Country
- HLN United Kingdom
- MIST Canada
- Employees
- HLN N/A
- MIST N/A
- Industry
- HLN Package Goods/Cosmetics
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- HLN Consumer Discretionary
- MIST Health Care
- Exchange
- HLN Nasdaq
- MIST Nasdaq
- Market Cap
- HLN 45.6B
- MIST 53.9M
- IPO Year
- HLN N/A
- MIST N/A
- Fundamental
- Price
- HLN $10.74
- MIST $1.11
- Analyst Decision
- HLN Buy
- MIST Strong Buy
- Analyst Count
- HLN 1
- MIST 2
- Target Price
- HLN $10.95
- MIST $9.50
- AVG Volume (30 Days)
- HLN 15.0M
- MIST 1.6M
- Earning Date
- HLN 02-27-2025
- MIST 05-20-2025
- Dividend Yield
- HLN 1.56%
- MIST N/A
- EPS Growth
- HLN 38.94
- MIST N/A
- EPS
- HLN 0.20
- MIST N/A
- Revenue
- HLN $14,062,871,660.00
- MIST N/A
- Revenue This Year
- HLN $4.78
- MIST N/A
- Revenue Next Year
- HLN $4.75
- MIST N/A
- P/E Ratio
- HLN $27.01
- MIST N/A
- Revenue Growth
- HLN N/A
- MIST N/A
- 52 Week Low
- HLN $8.12
- MIST $0.63
- 52 Week High
- HLN $10.80
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- HLN 60.96
- MIST 43.96
- Support Level
- HLN $10.57
- MIST $1.28
- Resistance Level
- HLN $10.85
- MIST $1.32
- Average True Range (ATR)
- HLN 0.14
- MIST 0.12
- MACD
- HLN 0.05
- MIST 0.02
- Stochastic Oscillator
- HLN 87.21
- MIST 27.39
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).